Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DXC5AT
|
||||
| Drug Name |
N-{(S)-2-(2-Chloro-phenyl)-1-[2-(4-methoxy-phenylamino)-ethylcarbamoyl]-ethyl}-3-methyl-benzamide
|
||||
| Synonyms |
CHEMBL370764
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C26H28ClN3O3
|
||||
| Canonical SMILES |
COc1ccc(NCCNC(=O)[C@H](Cc2ccccc2Cl)NC(=O)c3cccc(C)c3)cc1
|
||||
| InChI |
InChI=1S/C26H28ClN3O3/c1-18-6-5-8-20(16-18)25(31)30-24(17-19-7-3-4-9-23(19)27)26(32)29-15-14-28-21-10-12-22(33-2)13-11-21/h3-13,16,24,28H,14-15,17H2,1-2H3,(H,29,32)(H,30,31)/t24-/m0/s1
|
||||
| InChIKey |
MMOQDAMRMLPVQY-DEOSSOPVSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Cathepsin K | Target Info | [1587926] | ||
| Cathepsin L | Target Info | [1587926] | |||
| Reactome | Collagen degradation | ||||
| Degradation of the extracellular matrix | |||||
| Activation of Matrix Metalloproteinases | |||||
| Trafficking and processing of endosomal TLR | |||||
| MHC class II antigen presentationR-HSA-1236977:Endosomal/Vacuolar pathway | |||||
| Assembly of collagen fibrils and other multimeric structures | |||||
| MHC class II antigen presentation | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.